Dalah Entesar Z, Alkaabi Maryam K, Antony Nisha A, Al-Awadhi Hashim M
Central Diagnostic Imaging Department, Dubai Health, Dubai P.O. Box 2727, United Arab Emirates.
College of Medicine, Mohammed Bin Rashid University, Dubai Health, Dubai P.O. Box 2727, United Arab Emirates.
J Imaging. 2025 Mar 7;11(3):79. doi: 10.3390/jimaging11030079.
The aim of this patient dose review is to establish a thorough diagnostic reference level (DRL) system. This entails calculating a DRL value for each possible image technique/view considered to perform a diagnostic mammogram in our practice. Diagnostic mammographies from a total of 1191 patients who underwent a diagnostic mammogram study in our designated diagnostic mammography center were collected and retrospectively analyzed. The DRL representing our health sector was set as the median of the mean glandular dose (MGD) for each possible image technique/view, including the 2D standard bilateral craniocaudal (LCC/RCC) and mediolateral oblique (LMLO/RMLO), the 2D bilateral spot compression CC and MLO (RSCC/LSCC and RSMLO/LSMLO), the 2D bilateral spot compression with magnification (RMSCC/LMSCC and RMSMLO/LMSMLO), the 3D digital breast tomosynthesis CC and MLO (RCC/LCC and RMLO/LMLO), the 2D bilateral implant CC and MLO (RIMCC/LIMCC and RIMMLO/LIMMLO), the 2D bilateral contrast enhanced CC and MLO (RCECC/LCECC and RCEMLO/LCEMLO) and the 2D bilateral stereotactic biopsy guided CC (SBRCC/SBLCC). This patient dose review revealed that the highest MGD was associated with the 2D bilateral spot compression with magnification (MSCC/MSMLO) image view. For the compressed breast thickness (CBT) group 60-69 mm, the median and 75th percentile of the MGD values obtained were MSCC: 3.35 and 3.96, MSMLO: 4.14 and 5.25 mGy respectively. Obvious MGD variations were witnessed across the different possible views even for the same CBT group. Our results are in line with the published DRLs when using same statistical quantity and CBT group.
本次患者剂量评估的目的是建立一个全面的诊断参考水平(DRL)系统。这需要为我们实践中进行诊断性乳腺钼靶检查所考虑的每种可能的影像技术/视图计算一个DRL值。收集并回顾性分析了在我们指定的诊断性乳腺钼靶检查中心接受诊断性乳腺钼靶检查的总共1191名患者的诊断性乳腺钼靶图像。代表我们卫生部门的DRL被设定为每种可能的影像技术/视图的平均腺体剂量(MGD)的中位数,包括二维标准双侧头尾位(LCC/RCC)和内外侧斜位(LMLO/RMLO)、二维双侧点压头尾位和内外侧斜位(RSCC/LSCC和RSMLO/LSMLO)、二维双侧放大点压(RMSCC/LMSCC和RMSMLO/LMSMLO)、三维数字乳腺断层扫描头尾位和内外侧斜位(RCC/LCC和RMLO/LMLO)、二维双侧植入物头尾位和内外侧斜位(RIMCC/LIMCC和RIMMLO/LIMMLO)、二维双侧对比增强头尾位和内外侧斜位(RCECC/LCECC和RCEMLO/LCEMLO)以及二维双侧立体定向活检引导头尾位(SBRCC/SBLCC)。本次患者剂量评估显示,最高的MGD与二维双侧放大点压(MSCC/MSMLO)影像视图相关。对于压缩乳腺厚度(CBT)为60 - 69毫米的组,获得的MGD值的中位数和第75百分位数分别为MSCC:3.35和3.96,MSMLO:4.14和5.25毫戈瑞。即使对于相同的CBT组,在不同的可能视图中也观察到了明显的MGD变化。当使用相同的统计量和CBT组时,我们的结果与已发表的DRL一致。